http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102277739-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 |
| filingDate | 2019-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102277739-B1 |
| titleOfInvention | A composition for treating fibrosis diseases comprising benzhydrylthio acetamide compounds as an active ingredient |
| abstract | The present invention relates to a composition for the treatment of fibrotic diseases comprising a benzhydryl thioacetamide compound as an active ingredient. More specifically, it inhibits the expression of K Ca 2.3 channel protein in the cell membrane, in particular, liver fibrosis and lung It relates to a composition for the treatment of fibrotic diseases having excellent efficacy in treating fibrosis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230019795-A |
| priorityDate | 2019-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.